Norges Bank’s Astrana Health ASTH Stock Holding History

Norges Bank’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,256	Closed	-$643K	–	2181
2022 Q1	$643K	Buy	+13,256	New	+$684K	﹤0.01%	2086

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank's ASTH Position: Q2 2022 in Review

Norges Bank sold out of Astrana Health (ASTH) in Q2 2022, closing a stake of 13,256 shares — an estimated $643K sold.

Norges Bank first reported a position in ASTH in Q1 2022 and held it in 1 quarter. The position peaked at $643K in Q1 2022. 134 funds tracked by Wall St. Rank hold ASTH as of Q2 2022.

Norges Bank reported no remaining Astrana Health position as of Q2 2022 after selling out during the quarter.
Norges Bank sold 13,256 Astrana Health shares in Q2 2022, an estimated $643K.
Norges Bank first reported a position in Astrana Health in Q1 2022 and held it in 1 quarter.
Norges Bank's Astrana Health position peaked at $643K in Q1 2022.
134 funds tracked by Wall St. Rank held Astrana Health as of Q2 2022.

Based on Norges Bank's 13F filing for Q2 2022, filed 11 Aug 2022.